ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,211Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 1107

$903K Total Retail Price of All Prescriptions

Rank: 121 out of 1107

664 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

5% of this provider’s 15,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 742 639 1 2
SIMVASTATIN 691 599 2 5
TRIAMTERENE-HCTZ 618 551 10 3 62
AMLODIPINE BESYLATE 614 524 4 6
LEVOTHYROXINE SODIUM 524 423 5 3
ATORVASTATIN CALCIUM 520 440 6 13
HYDROCODONE-ACETAMINOPHEN 474 250 S3 7 1
METOPROLOL SUCCINATE 432 392 8 16
FUROSEMIDE 390 329 9 7
OMEPRAZOLE 374 313 10 4
GABAPENTIN 341 241 11 9
METFORMIN HCL ER 332 281 12 58
LOSARTAN POTASSIUM 312 266 13 29
GLIMEPIRIDE 302 252 14 43
PAROXETINE HCL 293 204 15 45
NEXIUM 275 206 16 18
PREMARIN 269 224 R 17 149
POTASSIUM CHLORIDE 265 215 18 14
PRAVASTATIN SODIUM 260 242 19 12
RAMIPRIL 258 258 20 84
DIOVAN 253 203 21 51
METOPROLOL TARTRATE 243 223 22 10
HYDROCHLOROTHIAZIDE 235 218 23 11
WARFARIN SODIUM 220 210 24 15
SERTRALINE HCL 213 152 25 20
AZITHROMYCIN 202 154 26 35
ATENOLOL 184 158 27 19
ALLOPURINOL 182 165 28 36
AMITRIPTYLINE HCL 173 133 R 29 48
CLOPIDOGREL 166 135 30 28
CARVEDILOL 159 130 31 27
ZOLPIDEM TARTRATE 157 117 32 22
LANTUS 145 125 33 49
JANUVIA 135 108 34 60
MELOXICAM 130 126 35 25
VERAPAMIL ER 123 121 36 113
METFORMIN HCL 121 91 37 8
LIPITOR 120 104 38 109
PLAVIX 118 105 39 39
TRAMADOL HCL 114 93 40 26
ZETIA 111 77 41 76
ESTRADIOL 108 106 R 42 151
LOSARTAN-HYDROCHLOROTHIAZIDE 106 96 43 66
TRIAMTERENE-HYDROCHLOROTHIAZID 106 88 43 185
SINGULAIR 105 98 45 65
DIGOXIN 102 102 46 52
CRESTOR 100 97 47 23
BUSPIRONE HCL 99 67 48 107
CYCLOBENZAPRINE HCL 91 79 R 49 56
INDAPAMIDE 90 90 50 183
CITALOPRAM HBR 87 51 51 17
CLONIDINE HCL 85 85 52 53
CARISOPRODOL 84 23 R 53 146
FAMOTIDINE 83 78 54 111
ESCITALOPRAM OXALATE 82 72 55 82
PROAIR HFA 79 69 56 37
MECLIZINE HCL 75 72 57 114
PROPRANOLOL HCL 68 56 58 134
CYMBALTA 68 53 58 50
SYNTHROID 68 68 58 70
CELEBREX 68 61 58 85
DOXAZOSIN MESYLATE 66 66 62 92
OXYCODONE-ACETAMINOPHEN 66 55 S2 62 104
AMLODIPINE BESYLATE-BENAZEPRIL 66 56 62 77
CILOSTAZOL 65 58 65 194
ENALAPRIL MALEATE 65 65 65 98
QUINAPRIL HCL 63 52 67 145
MONTELUKAST SODIUM 61 50 68 118
DOXYCYCLINE HYCLATE 60 49 69 128
AMOXICILLIN 60 34 69 90
POLYETHYLENE GLYCOL 3350 59 40 71 46
GLYBURIDE MICRONIZED 59 59 R 71 202
ALENDRONATE SODIUM 58 58 73 41
ACTOS 57 42 74 132
FLUTICASONE PROPIONATE 57 50 74 38
LANOXIN 55 55 76 386
NABUMETONE 55 51 76 181
PROMETHAZINE HCL 54 19 R 78 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 52 79 24
ALPRAZOLAM 52 52 80 87
LABETALOL HCL 52 42 80 245
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.